1. Chromosome Region Maintenance 1 (XPO1/CRM1) as an Anticancer Target and Discovery of Its Inhibitor
   Song Liu et al, 2021, Journal of Medicinal Chemistry CrossRef
2. Small Molecule Inhibitors of CRM1
   Bibiana I. Ferreira et al, 2020, Frontiers in Pharmacology CrossRef
3. Targeting XPO1-Dependent Nuclear Export in Cancer
   Ekaterina Kim et al, 2022, Biochemistry (Moscow) CrossRef
4. Therapeutic Targeting of Exportin-1 in Childhood Cancer
   Basia Galinski et al, 2021, Cancers CrossRef
5. Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors
   Antonella Lucia Marretta et al, 2021, Pharmaceutics CrossRef
6. Phenethyl isothiocyanate suppresses the metastasis of ovarian cancer associated with the inhibition of CRM1-mediated nuclear export and mTOR-STAT3 pathway
   Wen Yu Shao et al, 2017, Cancer Biology & Therapy CrossRef
7. Measuring and Interpreting Nuclear Transport in Neurodegenerative Disease—The Example of C9orf72 ALS
   Marije F. W. Semmelink et al, 2021, International Journal of Molecular Sciences CrossRef
8. Inhibition of chromosomal region maintenance 1 suppresses the migration and invasion of glioma cells via inactivation of the STAT3/MMP2 signaling pathway
   Qianqian Shan et al, 2020, The Korean Journal of Physiology & Pharmacology CrossRef
9. Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published Data
   Hai-Yong Ren et al, 2015, BioMed Research International CrossRef
10. Nuclear transport proteins are secreted by cancer cells and identified as potential novel cancer biomarkers
    Pauline J. van der Watt et al, 2022, International Journal of Cancer CrossRef